Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
100%
Receptor
50%
Eating Disorder
50%
Adrenergic Receptor
50%
Parkinson's Disease
50%
Randomized Controlled Trial
50%
Prevalence
50%
Tolerability
50%
Polypharmacy
50%
Noradrenalin
16%
Random Effects Model
16%
Schizoaffective Psychosis
16%
Treatment-Resistant Schizophrenia
16%
Comorbidity
15%
Automutilation
10%
Anorexia Nervosa
10%
Schizophrenia Spectrum Disorder
8%
Cognitive Defect
8%
Carbon 11
8%
Yohimbine
8%
Adverse Event
5%
Monotherapy
5%
All Cause Mortality
5%
Side Effect
5%
Prospective Cohort Study
5%
Diseases
5%
Neuroscience
Meta-Analysis
100%
Antipsychotic
100%
Eating Disorder
50%
Parkinson's Disease
50%
Receptor
50%
Adrenergic Receptor
50%
Body Mass Index
16%
Comorbidity
16%
Frontal Lobe
16%
Norepinephrine
16%
Autism
16%
Automutilation
11%
Anorexia Nervosa
11%
Schizophrenia Spectrum Disorder
8%
Thalamus
8%
Cognitive Process
8%
Cognitive Disorders
8%
Yohimbine
8%
Positron Emission Tomography
8%
Synaptic Transmission
8%
Mental Disorder
5%
Treatment of Eating Disorders
5%
Medicine and Dentistry
Meta-Analysis
50%
Randomized Clinical Trial
50%
Polypharmacy
50%
Systematic Review
50%
Parkinson's Disease
50%
Adrenergic Receptor
50%
Receptor
50%
Antipsychotic
50%
Monotherapy
19%
Frontal Lobe
16%
Noradrenalin
16%
Rhythm
16%
Positron Emission Tomography
8%
Quantitative Electroencephalography
8%
Thalamus
8%
Carbon 11
8%
Yohimbine
8%
Cognitive Defect
8%
Volunteer
8%
Synaptic Transmission
8%
Side Effect
5%
